The prevalence of gene alterations in gastric cancer was also compared to the MSKCC cohort (n = 81), and revealed a higher mutation frequency in TP53 and lower mutation frequency in PBRM1 and ERBB3 (Figure 5A). This evidence concerns the gene ERBB3 and gastric cancer.